LOGIN  |  REGISTER
Chimerix

DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report

May 14, 2024 | Last Trade: US$160.33 5.97 3.87

DENVER, May 14, 2024 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its 2023 Community Care Report, underscoring its dedication to corporate social responsibility and commitment to setting a new standard for health care services. DaVita's annual Community Care Report examines progress toward its 2025 Environmental, Social, and Governance (ESG) goals to help improve the lives of patients and support the health of communities globally.

 

The report highlights 2023 milestones across five strategic focus areas:

  • Patient Care
  • Teammate Engagement
  • Environmental Stewardship
  • Healthy Communities
  • Leading with Integrity and Accountability

"The sustained progress outlined in this report underscores our vision for an unwavering pursuit of a healthier tomorrow," said Javier Rodriguez, chief executive officer for DaVita. "Building a healthier tomorrow begins with excellence in patient care and extends to our positive impact on the communities we serve. I'm proud to work alongside dedicated teammates who are deeply committed to uplifting our patients, each other and our world."

Following are 2023 standout achievements from each of the five focus areas reflected in the report.

Patient Care

  • 8,000+ DaVita patients received a kidney transplant, the provider's highest number of annual transplants to date
  • 37,000+ people participated in Kidney Smart®, DaVita's award-winning kidney disease education program, which is available in more than ten languages
  • DaVita conducted unique health equity and social determinants of health pilot programs across the country focused on transplant equity and community-based chronic kidney disease education
  • DaVita launched Mozarc Medical with Medtronic, a new kidney health technology company dedicated to improving access to home dialysis

Teammate Engagement

  • 49,000+ clinical teammates are a part of DaVita's innovative career pathways program, Clinical Ladders
  • 2,300+ teammates are pursuing or have received their nursing degree, funded by DaVita, as part of its Bridge to Your Dreams program
  • ~60% of DaVita facility administrators and managers have been promoted internally
  • Operational managers who lead DaVita's dialysis centers are 78% women and 40% people of color

Environmental Stewardship

  • DaVita's virtual power purchase agreements continued to produce enough renewable energy to power 100% of its U.S. operations
  • DaVita's net-zero dialysis center, the first of its kind in the U.S., became operational
  • More than 100 million gallons of water were saved through water efficiency projects
  • DaVita became the only North American health care provider to receive a CDP climate change score in the highest "Leadership" category, with a score of "A-"

Healthy Communities

  • The 2023 DaVita Health Tour provided thousands of community members across the country with free health screenings and education focused on kidney health
  • DaVita teammates recorded 43,000+ volunteer hours, contributing to a record-setting year for volunteerism
  • DaVita and the American Diabetes Association collaborated to provide educational content aimed at helping those living with diabetes prevent and manage kidney disease
  • Through support from the DaVita Giving Foundation, the Food is Medicine Coalition provided more than 140,000 medically tailored meals to people with food insecurity and medical nutrition needs, including individuals living with end stage kidney disease

Leading with Integrity & Accountability

  • 99.9% of DaVita teammates completed annual compliance training in 2023, contributing to more than 90,000 hours dedicated to compliance learning and development

To learn more about DaVita's vision for corporate citizenship or to download the full report, visit DaVita.com/CommunityCare.

Forward Looking Statements:

This press release contains or refers to certain forward-looking statements within the meaning of the federal securities laws including, among other things. Without limiting the foregoing, statements including the words "expect," "intend," "will," "may," "continue," "target," "goal" and similar expressions are intended to identify forward-looking statements. The Company bases its forward-looking statements on information available to it on the date of this press release, and undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may otherwise be required by law. Actual future events could also differ materially due to numerous factors that involve substantial known and unknown risks and uncertainties including, among other things, the risks and uncertainties set forth under "Risk Factors" and elsewhere in the Company's reports on Form 10-K and Form 10-Q and the other risks and uncertainties discussed in any subsequent reports that the Company files with the Securities and Exchange Commission from time to time.

About DaVita Inc.

DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2024, DaVita served approximately 258,600 patients at 3,092 outpatient dialysis centers, of which 2,665 centers were located in the United States and 427 centers were located in 12 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

CONTACTS:
DaVita Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB